Shardul Amarchand Mangaldas: Healthify Berry Street Deal Shapes India-US Health Tech

• Shardul Amarchand Mangaldas & Co. advised Singapore-India based Healthify on its strategic combination with US-based Berry Street.
• The deal unites Healthify’s pioneering consumer AI technology with Berry Street’s insurance-covered clinical care network in the United States.
• The combined business will be co-led by Noah Kotlove, former CEO of Berry Street, and Tushar Vashisht, former CEO of Healthify.
• This transaction exemplifies a cross-border merger in the health technology sector involving an Indian-origin entity and a US company.

The core of this strategic alliance lies in the fusion of Healthify’s pioneering consumer artificial intelligence (AI) technology with Berry Street’s extensive insurance-covered clinical care network, which operates across the United States.

Leading Indian law firm Shardul Amarchand Mangaldas & Co. provided comprehensive legal counsel to Healthify in its recent strategic combination with US-based Berry Street. This significant transaction brings together distinct capabilities from two geographically diverse entities, marking a notable development in the global health technology sector.

Healthify, an entity with operations spanning Singapore and India, engaged in this strategic merger with Berry Street, a company firmly established in the United States. The deal represents a concerted effort to integrate advanced technological solutions with established healthcare service delivery models, aiming to create a more robust and expansive offering in the health tech landscape.

The core of this strategic alliance lies in the fusion of Healthify’s pioneering consumer artificial intelligence (AI) technology with Berry Street’s extensive insurance-covered clinical care network, which operates across the United States. This integration is designed to leverage Healthify's innovative digital health platforms and AI-driven insights alongside Berry Street's direct patient care and established reimbursement pathways within the American healthcare system. The combined entity is poised to offer a more holistic and integrated approach to health management, bridging the gap between cutting-edge technology and accessible clinical services.

Following the completion of this strategic combination, the newly formed business will operate under a co-leadership model, ensuring continuity and leveraging the expertise of both founding organizations. Tushar Vashisht, who previously served as the Chief Executive Officer of Healthify, will assume the role of co-CEO for the integrated enterprise.

Joining Mr. Vashisht in this shared leadership capacity will be Noah Kotlove, who previously held the position of Chief Executive Officer at Berry Street. This dual leadership structure is intended to facilitate a smooth transition and foster a collaborative environment, drawing on the strengths and strategic visions of both executives to guide the combined business forward. Their joint leadership underscores the commitment to integrating the respective technologies and networks effectively, aiming for synergistic growth and expanded market reach.

The advisory role played by Shardul Amarchand Mangaldas & Co. in this transaction highlights the increasing complexity and cross-border nature of mergers and acquisitions within the health technology sector. Their involvement underscores the critical legal expertise required to navigate strategic combinations between companies operating in different jurisdictions, specifically an India-Singapore based entity and a US-based counterpart.

This particular Shardul Amarchand Mangaldas corporate transaction serves as a pertinent example of an India US health tech M&A deal, showcasing how Indian legal firms are instrumental in facilitating international strategic combinations. The successful execution of this cross-border merger involving an Indian-origin company like Healthify and a US entity like Berry Street reflects the growing global interconnectedness of the health tech industry and the specialized legal support necessary for such intricate deals. The SAM Healthify Berry Street advisory engagement illustrates the firm's capability in handling complex international corporate transactions, particularly those at the intersection of technology and healthcare.

This transaction serves as a recent market example of a prominent Indian law firm advising on a cross-border strategic combination between an Indian tech company and a US entity. It is relevant for M&A practitioners tracking deal precedents and the evolving landscape of international health tech mergers.

Source: Original reporting via SCC Times